CEO Corner
-
Biopharma Companies Are Focused On Access, Continued Innovation
7/1/2016
Our shared goal should be to design an economically sustainable system that ensures patient access and promotes future innovation. Here are a few keys to consider as we work toward this goal.
-
In A Political Year, We Need To Remember The Value Of Pharma/Bio
6/1/2016
The drug pricing debate has been particularly challenging for our industry, and, with the presidential election coming up, I can’t help feeling that the attacks will only get worse.
This website uses cookies to ensure you get the best experience on our website. Learn more